Liminatus Pharma, Inc. Class A Common Stock logo

Liminatus Pharma, Inc. Class A Common Stock

LIMNNASDAQStock Fundamentals

Liminatus Pharma, Inc. Class A Common Stock is a publicly traded company trading on NASDAQ, led by CEO Chris Kim, with a market cap of $7.4M.

Market Cap$7.4M
CEOChris Kim
CountryUnited States of America
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View report

Financials

Based on Q1 2026 filing

LIM

Liminatus Pharma, Inc. Class A Common Stock FAQ

Common questions about Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a market capitalization of $7.4M and trades on NASDAQ.